Cytokine-induced NK-like T cells: from bench to bedside.
about
Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic reviewGlobal transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor.Immunotherapeutic Intervention against Sarcomas.Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8(+) T cellsEvaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancerCytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response.Cytokine-induced killer (CIK) cells: from basic research to clinical translation.Dynamic tracing of immune cells in an orthotopic gastric carcinoma mouse model using near-infrared fluorescence live imaging.Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safetyAdjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancerEnhancing cytokine-induced killer cell therapy of multiple myeloma.Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion.Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignanciesNew advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.New adoptive immunotherapy strategies for solid tumours with CIK cells.Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies.Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.Cytokine-induced killer cells: A novel treatment for allergic airway inflammation.CIK cells--current status, clinical perspectives and future prospects--the good news.Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.
P2860
Q27026977-7DE5B275-F7A7-478A-8AD5-1F2E0F8BD961Q34050208-1850FF22-F9B4-4F42-96D7-BD52BFF5F2F8Q34196481-ECEE7120-1F54-41EF-830B-06B68C680DF2Q34329186-EB9B8FAC-FD34-41B6-881B-C96AD8CAD5D9Q34419059-D49FF9F4-A719-472E-82EE-A020F1B90174Q34539858-CD6A2E74-80F0-4FF6-BE69-7BDB4442D487Q34635795-284B0FD6-EE24-4955-8197-7191F685AF98Q34777479-2E0F426D-A0F1-437A-A9B4-85E676D9202CQ35167582-4A4A3D29-4C51-4836-8B67-0CB0DD9B30BAQ36121153-65EE2FAB-6253-4B33-81EE-B4F1E0964F6FQ36285693-0FF9D1E1-62D3-4893-8062-48871A525383Q36444510-F60A32DA-FD3E-4623-B146-3D20609546A5Q36566943-C172AEB7-8013-41D3-B7D1-B5693C75792AQ36740905-70CEFFF4-8EBC-47DC-966C-DA614F9E5AE2Q36892290-D5DE6D26-4C7B-4BDC-846B-7B2E9B791A4BQ37395436-D68D47E5-A052-4BF2-A667-2C50DEFEEDA2Q37443674-85279881-359F-40C4-800E-D1B0A191E0D4Q37560863-9C152B9C-FA0E-4DD3-A8EB-1D1E3D1500B9Q37937083-CEB5469D-943D-4FFE-8583-BD98A7C662B3Q37996561-ED34A9B7-85B7-4E56-B3CB-CE7C737845A2Q38002494-6C983DBA-A18B-49FD-ADE6-D3FE0B3187D5Q38088013-75C8A23F-F608-4705-A5D8-8A6E507CD905Q38634685-AB2CFD12-9A05-42A7-AB8D-A478587801FCQ38740111-896DEEF5-EEEF-4E3C-B053-DB9CF1A92211Q41973053-FD51F8EE-C7DD-4A5E-8419-D4114717438CQ42274903-6EB8E656-C1E1-4394-A32D-A6A1BA6B1966Q47119845-D310C4B9-2C95-4B61-AABF-374C86AC5F44Q51610220-712894EF-C963-41D9-BD58-4791881D54F5Q52882119-C4B242AE-F120-4308-BF66-8D82F747BD0AQ54986388-BEDE0060-68DF-43B5-AE45-EA136DBD160A
P2860
Cytokine-induced NK-like T cells: from bench to bedside.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cytokine-induced NK-like T cells: from bench to bedside.
@ast
Cytokine-induced NK-like T cells: from bench to bedside.
@en
type
label
Cytokine-induced NK-like T cells: from bench to bedside.
@ast
Cytokine-induced NK-like T cells: from bench to bedside.
@en
prefLabel
Cytokine-induced NK-like T cells: from bench to bedside.
@ast
Cytokine-induced NK-like T cells: from bench to bedside.
@en
P2860
P921
P356
P1476
Cytokine-induced NK-like T cells: from bench to bedside.
@en
P2093
Yeh Ching Linn
P2860
P304
P356
10.1155/2010/435745
P577
2010-03-30T00:00:00Z